GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2
WEB14 hours ago · CNN —. GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced ...
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
WEB13 hours ago · The Food and Drug Administration asked in 2020 that all Zantac products, which relied on a heartburn drug developed by GSK, be taken off the market. The current Zantac 360 uses a different active ...
GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement …
WEB19 hours ago · On Wednesday, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% ...
GSK to Settle 80,000 Zantac Cases for Up to $2.2 Billion
WEB20 hours ago · GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen.
Statement: Zantac (ranitidine) litigation – settlement agreements ...
WEBGSK also confirms that it has reached an agreement in principle to pay a total of $70 million to resolve the Zantac qui tam complaint previously filed by Valisure. The agreement in principle is subject to final approval from the Department of Justice (the “ Qui Tam Settlement”). GSK has not admitted any liability in the State Courts ...
Statement: Zantac (ranitidine) litigation – settlement ... - GSK
WEB20 hours ago · 09 October 2024. Issued: London, UK. For media and investors only. Statement: Zantac (ranitidine) litigation – settlement agreements reached. Download (PDF, 130.6KB) GSK to resolve 93% (approximately 80,000 cases) of U.S. state court Zantac product liability cases for up to $2.2 billion. …
Zantac maker GSK agrees to pay $2.3 bn in US settlements
WEB18 hours ago · British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.
GSK to pay $2.2B to settle most Zantac lawsuits over claims pill
WEB19 hours ago · After protracted legal battling, GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac heartburn medication caused cancer. The ...
Pharma giant GSK to pay $2.2 to settle Zantac lawsuits - BBC
WEBUK firm GSK to pay $2.2bn over Zantac cancer claims. UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a ...
FDA Requests Removal of All Ranitidine Products (Zantac) from …
WEBThe U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.